BioCentury | Feb 5, 2021
Management Tracks
Big shoes: Davis needs to fill Merck’s post-Keytruda pipeline as Frazier shifts to executive chair
...business development and strategy and investor relations.Prior to Merck, Davis had a 10-year tenure at Baxter International...